Beruflich Dokumente
Kultur Dokumente
THERAPY
Gene Therapy
It is a technique for correcting defective
The Beginning
In the 1980s, Scientists began to look into gene therapy.
into human
cells, focusing diseases caused by single-gene defects, such as cystic
fibrosis,
hemophilia, muscular dystrophy and sickle cell anemia. However this
has been
much harder than modifying simple bacteria, primarily because of the
problems
involved in carrying large section of DNA and delivery it to the right
site on the
genome
1.
Vectors used in
gene therapy :
mainly viruses
Why Viruses ?
A virus is the simplest organism there isit is pretty much just
genetic material wrapped up in a protein coat.
a virus cant live on its own
it survives and multiplies by parasitically attacking living cells
and injecting its genetic material into cells.
The fact that many viruses are cell specific (e.g., a certain
virus may only infect heart cells or lung cells) helps scientists
target just the desired cells.
DNA out of the virus and add to it the desired gene segment.
Retroviruses
Created double stranded DNA copies from RNA genome
The retrovirus goes through reverse transcription
using reverse transcriptase and RNA
the double stranded viral genome integrates into
the human genome using integrase .
integrase inserts the gene anywhere because it
has no specific site
Adenoviruses
Adenoviruses carry their genetic material in the form of DNA.
When these viruses infect a host, they introduce their DNA
molecule into the host but not incorporated into the host
genetic material.
These extra genes are not replicated, so when the host undergo
cell division, the descendants of the cell will not have the extra
gene.
This means that treatment with adenovirus will require regular
doses to add the missing gene every time.
Adenoviruses can invade slower dividing cells, such as lung
cells
Like retroviruses, immune response may reduce its
effectiveness
Adenovirus cont
http://en.wikipedia.org/wiki/Gene_therapy
Adeno-associated Viruses
Adeno-associated viruses are believed to occur naturally in
Continued
hemophilia treatments, for example, a genecarrying vector could be injected into a muscle,
prompting the muscle cells to produce Factor IX
and thus prevent bleeding.
Study by Wilson and Kathy High (University
of Pennsylvania), patients have not needed
Factor IX injections for more than a year
NON-VIRAL OPTIONS
Direct introduction of therapeutic
DNA
http://www.wellesley.edu/Biology/Courses/219/Gen_news/i3_Gene_Therapy.jpg
Thank You